Clinical Trials on Cancer, Hepatocellular

Total 53110 results

Henri Mondor University Hospital

Unknown

Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma

Primary Liver Cancers

France
AHS Cancer Control Alberta

Not yet recruiting

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Pancreatic Cancer | Cholangiocarcinoma | Biliary Tract Cancer | Hepatocellular Cancer

Canada
Centre hospitalier de l'Université de Montréal...
Canadian Institutes of Health Research (CIHR); Centre de Recherche du Centre...

Not yet recruiting

Early Detection of Liver Cancer by QUS (QUS in HCC)

Hepatocellular Carcinoma | Liver Cancer

Canada
Seoul National University Hospital
Guerbet

Recruiting

TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma (IDADOX) (IDADOX)

Hepatocellular Carcinoma | Liver Cancer

Korea, Republic of
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer

Hepatocellular Carcinoma

China
TaiRx, Inc.

Recruiting

CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Advanced Cancer

Taiwan
AIO-Studien-gGmbH
Bristol-Myers Squibb

Completed

Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma (IMMUTACE)

Carcinoma, Hepatocellular | Hepatocellular Cancer | Hepatic Carcinoma

Germany
M.D. Anderson Cancer Center
Genentech, Inc.; OSI Pharmaceuticals

Completed

Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy

Liver Cancer

United States
Stanford University
BTG International Inc.

Approved for marketing

A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma

Liver Cancer

United States
RenJi Hospital

Completed

Effects of Anesthetic Methods on Hepatic Cancer Cell Function in Vitro

Hepatocellular Carcinoma

China
University of Texas Southwestern Medical Center

Withdrawn

Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events

Hepatocellular Carcinoma
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and...

Completed

SU011248 in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer

United States
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Gastro Intestinal Surgery and Liver Transplantation; The Hepato-Oncology Group...

Completed

Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer

Italy
University of New Mexico

Completed

Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma

Cancer | Liver

United States
Sun Yat-sen University

Unknown

Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma (RFA and TACE)

Hepatocellular Carcinoma | Liver Cancer

China
Edward Kim
Bristol-Myers Squibb; National Cancer Institute (NCI)

Terminated

BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer

Unresectable Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma... and other conditions

United States
Chinese University of Hong Kong

Not yet recruiting

Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors (PDO)

Hepatocellular Carcinoma | Colorectal Cancer

Hong Kong
University of Oxford
University of Nottingham; Cancer Research UK; Glasgow Caledonian University; Pe... and other collaborators

Recruiting

The Detection of Small Early Liver Cancer With Natural History Follow up (SELINA)

Hepatocellular Carcinoma

United Kingdom
Duke University

Recruiting

Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients

Liver Cancer

United States
Stanford University

Recruiting

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

Liver Cancer

United States
TaiRx, Inc.

Terminated

CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Advanced Cancer

Taiwan, United States
Juan José Ciampi Dopazo

Unknown

Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCC

Hepatocellular Carcinoma | Liver Cancer

Spain
National Taiwan University Hospital

Completed

Effects of Telephone Consultations on Discharged Liver Cancer

Hepatocellular Carcinoma

Taiwan
Guangxi Medical University

Unknown

HR Versus RFA for Early Stage HCC (ARTC-HCC)

Hepatocellular Carcinoma | Liver Cancer

China
Guangxi Medical University

Unknown

Celebrex and Metformin for Postoperative Hepatocellular Carcinoma (XBD)

Liver Cancer

China
New Mexico Cancer Care Alliance

Completed

Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter

Liver Cancer

United States
Sun Yat-sen University

Unknown

Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma (LAM-RFA)

Hepatocellular Carcinoma | Liver Cancer

China
Sun Yat-sen University

Unknown

Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma (RT-RFA)

Hepatocellular Carcinoma | Liver Cancer

China
Sichuan University

Recruiting

Personalized DC Vaccine for Postoperative Cancer

Hepatocellular Carcinoma | Gastric Cancer | Non-Small-Cell Lung Cancer | Colon Rectal Cancer

China
National Cancer Institute (NCI)

Terminated

Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer

Melanoma | Colon Cancer | Gastrointestinal Cancer | Hepatocellular Cancer | Genitourinary Cancer

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; American Society of Clinical Oncology; Radiological... and other collaborators

Withdrawn

Y-90 Versus SBRT for Inoperable HCC

Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma AJCC v8 | Stage IB Hepatocellular Carcinoma AJCC v8 | Stage II Hepatocellular Carcinoma AJCC v8 | Stage... and other conditions

United States
Sun Yat-sen University

Recruiting

TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer

Hepatocellular Carcinoma

China
Sherief Abd-Elsalam
Tanta University

Recruiting

Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma

Liver Cancer

Egypt
Tang-Du Hospital

Completed

Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function

Hepatic Cancer

China
M.D. Anderson Cancer Center
Exelixis

Withdrawn

A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy

Hepatocellular Carcinoma | Liver Cancer

United States
Genetron Health
Peking University First Hospital; Xiangya Hospital of Central South University and other collaborators

Enrolling by invitation

Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients

Liver Cancer

China
Assiut University

Unknown

Trans-arterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Study of Different Outcomes and Their Predictive Factors

Liver Cancer

Egypt
RenJi Hospital

Completed

Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy

Hepatocellular Carcinoma

China
Federation Francophone de Cancerologie Digestive

Completed

Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II (IDASPHERE II)

Liver Cancer

France
Tan Tock Seng Hospital
AstraZeneca; Singapore Cancer Syndicate.

Unknown

Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma

Liver Cancer

Singapore
University of Southern California

Unknown

A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer

United States
Qingdao Central Hospital

Completed

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

Liver Cancer

China
Kyowa Kirin Co., Ltd.

Completed

A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) (JET-HCC)

Liver Cancer

Japan
University of Alabama at Birmingham
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Terminated

Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma (RAD 0901)

Hepatocellular Carcinoma | Liver Cancer

United States
National Taiwan University Hospital

Completed

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

Liver Cancer

Taiwan
Loma Linda University

Completed

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer

United States
Sun Yat-sen University

Unknown

Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma (LDT-RFA)

Hepatocellular Carcinoma | Liver Cancer

China
Sun Yat-sen University

Unknown

TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma (TACE-RFA)

Hepatocellular Carcinoma | Liver Cancer

China
Bristol-Myers Squibb

Active, not recruiting

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

Hepatocellular Carcinoma | Hepatoma | Liver Cell Carcinoma | Liver Cancer, Adult | Liver Cell Carcinoma, Adult

Chile, Brazil, Argentina, China, Czechia, France, Hong Kong, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Singapore, Spain, Taiwan, Turkey
European Hepatocellular Cancer Liver Transplant...

Completed

A Worldwide Score for Hepatocellular Cancer and Liver Transplantation (TRAIN-SCORE)

Recurrence | Liver Cancer | Dropout, Patient

Belgium

Clinical Trials on Cancer, Hepatocellular

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations